Efficacy and safety of taxanes combined with chemotherapy drugs in advanced triple negative breast cancer: A meta-analysis of 26 randomized controlled trials

BACKGROUND: Researchers have demonstrated that the combined use of taxanes and chemotherapy drugs, especially paclitaxel-based treatment, appeared to clinically benefit on advanced triple negative breast cancer (TNBC). This meta-analysis aims to obtain the existent evidence on efficacy and safety fo...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Qionglian, Mei, Zubing, Han, Xianghui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9471016/
https://www.ncbi.nlm.nih.gov/pubmed/36119468
http://dx.doi.org/10.3389/fonc.2022.972767

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9471016/
https://www.ncbi.nlm.nih.gov/pubmed/36119468
http://dx.doi.org/10.3389/fonc.2022.972767

Ejemplares similares